A pilot trial of 42 overweight survivors finds a more favorable weight-change pattern when mindfulness is added to an online diet and exercise program....
A new computational framework based on persistent homology extracts cancer-associated gene signatures that are sharper and more biologically coherent than conventional gene-selection methods....
A cost-effectiveness analysis from the US payer perspective concludes that the combination does not meet the willingness-to-pay threshold without a price cut of about 80%....
An engineered nanomaterial combines chemodynamic therapy and immunotherapy and remodels the tumor's immunosuppressive environment in preclinical primary and metastatic breast cancer models....
A review of 65 studies finds AI adds most value in imaging and non-linear prediction, while conventional regression is still preferred on structured data....
A review of 14 trials with 2,447 survivors finds that multimodal, professionally delivered therapies work better than minimally structured digital programmes....
Japanese patients and providers find evidence-based videos useful for communicating hereditary risk; only 20% of providers feel they convey all necessary information in consultation....
A Luxembourg pilot combines a cancer registry, occupational health records and surveys: 77% of participants returned to work after breast cancer, especially younger women....
Across three independent cohorts, low PGR expression is linked to higher genomic risk and poorer prognosis, but the study does not assess treatment response....
A recommender system tested with ten patients helps assess and manage symptoms of breast cancer treatment, with initially positive usability and acceptability ratings....
A Hungarian socioeconomic model estimates that treating early-stage cancer with anti-PD-(L)1 agents increases quality-adjusted life-years and patients' and caregivers' working years....
A US economic model estimates that comprehensive sequencing directs more patients to targeted therapies with minimal budget impact compared with 50-gene panels....